ADIPOQ and metabolic syndrome: Moreover, several studies in humans have shown that low circulating levels of adiponectin are associated with obesity [1,5], Type 2 diabetes [6] and metabolic syndrome [7], suggesting a strong link between adiponectin and insulin resistance [3].